Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_assertion type Assertion NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_head.
- NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_assertion description "[Oncolytic measles virus (MV) encoding the human thyroidal sodium iodide symporter (MV-NIS) has proved to be safe after intraperitoneal or intravenous administration in patients with ovarian cancer or multiple myeloma, respectively, but it has not yet been administered through intratumoral injection in humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_provenance.
- NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_assertion evidence source_evidence_literature NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_provenance.
- NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_assertion SIO_000772 22235810 NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_provenance.
- NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_assertion wasDerivedFrom befree-20150227 NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_provenance.
- NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_assertion wasGeneratedBy ECO_0000203 NP697611.RANC4XTupNDW367V0Xb4pd6VmzS5p1BylLtKMGLz2nnaQ130_provenance.